172 related articles for article (PubMed ID: 21080762)
21. Biphasic effects of ANP infusion in conscious, euvolumic rats: roles of AQP2 and ENaC trafficking.
Wang W; Li C; Nejsum LN; Li H; Kim SW; Kwon TH; Jonassen TE; Knepper MA; Thomsen K; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F530-41. PubMed ID: 16174867
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP
Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330
[TBL] [Abstract][Full Text] [Related]
24. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
Leehey DJ; Gollapudi P; Deakin A; Reid RW
J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
[TBL] [Abstract][Full Text] [Related]
25. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
Al Therwani S; Malmberg MES; Rosenbaek JB; Bech JN; Pedersen EB
BMC Nephrol; 2017 Aug; 18(1):268. PubMed ID: 28810844
[TBL] [Abstract][Full Text] [Related]
26. Vasotocin analogues with selective natriuretic, kaliuretic and antidiuretic effects in rats.
Kutina AV; Marina AS; Shakhmatova EI; Natochin YV
Regul Pept; 2013 Aug; 185():57-64. PubMed ID: 23835093
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
[TBL] [Abstract][Full Text] [Related]
28. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
29. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
30. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
Solà E; Lens S; Guevara M; Martín-Llahí M; Fagundes C; Pereira G; Pavesi M; Fernández J; González-Abraldes J; Escorsell A; Mas A; Bosch J; Arroyo V; Ginès P
Hepatology; 2010 Nov; 52(5):1783-90. PubMed ID: 20931555
[TBL] [Abstract][Full Text] [Related]
31. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study.
Therapondos G; Stanley AJ; Hayes PC
J Gastroenterol Hepatol; 2004 Jan; 19(1):73-7. PubMed ID: 14675246
[TBL] [Abstract][Full Text] [Related]
32. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
Gill JR; Casper AG
J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration.
Tian Y; Serino R; Verbalis JG
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F797-805. PubMed ID: 15213068
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: insight into pathogenesis of hypouricemia in SIADH.
Taniguchi K; Tamura Y; Kumagai T; Shibata S; Uchida S
Clin Exp Nephrol; 2016 Dec; 20(6):845-852. PubMed ID: 26935049
[TBL] [Abstract][Full Text] [Related]
35. Aldosterone-mediated apical targeting of ENaC subunits is blunted in rats with streptozotocin-induced diabetes mellitus.
O'Neill H; Lebeck J; Collins PB; Kwon TH; Frøkiaer J; Nielsen S
Nephrol Dial Transplant; 2008 May; 23(5):1546-55. PubMed ID: 18029369
[TBL] [Abstract][Full Text] [Related]
36. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis.
Ivarsen P; Frøkiaer J; Aagaard NK; Hansen EF; Bendtsen F; Nielsen S; Vilstrup H
Gut; 2003 Aug; 52(8):1194-9. PubMed ID: 12865281
[TBL] [Abstract][Full Text] [Related]
37. Urinary excretion of urodilatin in patients with cirrhosis.
Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
[TBL] [Abstract][Full Text] [Related]
38. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
39. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
Schrier RW; Fassett RG; Ohara M; Martin PY
Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin regulation of renal sodium excretion.
Stockand JD
Kidney Int; 2010 Nov; 78(9):849-56. PubMed ID: 20736986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
